Related Experiment Video
Updated: Dec 17, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
High blood pressure predicts hippocampal atrophy rate in cognitively impaired elders
Cassidy M Fiford1, Jennifer M Nicholas2, Geert Jan Biessels3
1Department of Neurodegenerative Disease, Dementia Research Centre UCL Institute of Neurology London UK.
Introduction:
Understanding relationships among blood pressure (BP), cognition, and brain volume could inform Alzheimer's disease (AD) management.
Methods:
We investigated Alzheimer's Disease Neuroimaging Initiative (ADNI) participants: 200 controls, 346 mild cognitive impairment (MCI), and 154 AD. National Alzheimer's Co-ordinating Center (NACC) participants were separately analyzed: 1098 controls, 2297 MCI, and 4845 AD. Relationships between cognition and BP were assessed in both cohorts and BP and atrophy rates in ADNI. Multivariate mixed linear-regression models were fitted with joint outcomes of BP (systolic, diastolic, and pulse pressure), cognition (Mini-Mental State Examination, Logical Memory, and Digit Symbol) and atrophy rate (whole-brain, hippocampus).
Results:
ADNI MCI and AD patients with greater baseline systolic BP had higher hippocampal atrophy rates ([r, P value]; 0.2, 0.005 and 0.2, 0.04, respectively). NACC AD patients with lower systolic BP had lower cognitive scores (0.1, 0.0003).
Discussion:
Higher late-life BP may be associated with faster decline in cognitively impaired elders.
More Related Videos
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Related Concept Videos
Role of Hippocampus in Memory
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Pharmacodynamics in Geriatric Patients: Effects of Age